Spire Healthcare, Britain's largest private hospital provider, is in advanced talks with private equity firms over a potential sale that could push the company off the London Stock Exchange. The deal, which has already sent shares soaring by 18%, values Spire at nearly Β£850m.
The company, which owns hospitals in Sheffield and south London, has been engaged in discussions with Bridgepoint Advisers and Triton Investments Advisers for several weeks. While talks are still in their early stages, the offer could mark a significant shift for Spire, which is under pressure from investors to address concerns about its value.
Spire's struggles have been well-documented. Despite owning 38 hospitals and more than 50 clinics across England, Wales, and Scotland, the company has seen NHS work volumes slow, impacting its profits. The company's shares have come under strain due to this decline, with Harwood Capital Management, one of its largest shareholders, warning that the current share price does not reflect the value of Spire's portfolio.
The private healthcare provider has been working closely with the NHS, but tensions are growing over privatisation concerns. Critics argue that the increasing reliance on private providers is eroding access to treatment for those who cannot afford it, creating a two-tiered system where wealth determines health outcomes.
Spire's chief executive, Justin Ash, has called for greater collaboration between private and public sector providers to address NHS waiting lists and reduce healthcare costs. However, with investors pressing for change, it remains to be seen whether Spire will accept an offer from the private equity firms or continue on its current trajectory.
The company, which owns hospitals in Sheffield and south London, has been engaged in discussions with Bridgepoint Advisers and Triton Investments Advisers for several weeks. While talks are still in their early stages, the offer could mark a significant shift for Spire, which is under pressure from investors to address concerns about its value.
Spire's struggles have been well-documented. Despite owning 38 hospitals and more than 50 clinics across England, Wales, and Scotland, the company has seen NHS work volumes slow, impacting its profits. The company's shares have come under strain due to this decline, with Harwood Capital Management, one of its largest shareholders, warning that the current share price does not reflect the value of Spire's portfolio.
The private healthcare provider has been working closely with the NHS, but tensions are growing over privatisation concerns. Critics argue that the increasing reliance on private providers is eroding access to treatment for those who cannot afford it, creating a two-tiered system where wealth determines health outcomes.
Spire's chief executive, Justin Ash, has called for greater collaboration between private and public sector providers to address NHS waiting lists and reduce healthcare costs. However, with investors pressing for change, it remains to be seen whether Spire will accept an offer from the private equity firms or continue on its current trajectory.